Short Interest in Sonova Holding (OTCMKTS:SONVY) Decreases By 73.3%

Sonova Holding (OTCMKTS:SONVY) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totaling 3,122 shares, a decrease of 73.3% from the March 15th total of 11,701 shares. Based on an average trading volume of 137,669 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SONVY. Zacks Research upgraded Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Finally, BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Sonova has an average rating of “Moderate Buy”.

Sonova Price Performance

Sonova stock opened at $46.22 on Friday. Sonova has a 52-week low of $42.26 and a 52-week high of $68.76. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The stock has a fifty day moving average price of $48.81 and a two-hundred day moving average price of $51.71.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.